The Abell Venture Fund

The Abell Venture Fund, based in Baltimore, Maryland, focuses on investing in companies located within Baltimore City across various industries. The fund typically participates in Seed and Series A rounds but also engages in other stages such as Pre-Seed, Series B, Series C, and Series D. Their investments range from small seed funding to larger rounds, reflecting their commitment to fostering local entrepreneurship and innovation.

Notable portfolio companies include LifeSprout, Pixelligent, and eNeura Therapeutics, showcasing a diverse investment range from biotech to advanced materials. The fund is led by key decision-makers with a deep commitment to improving Baltimore's economic and educational outcomes. The Abell Venture Fund offers unique value-add services by leveraging its non-profit status to focus on workforce development, education, justice, conservation, health, and human services, thereby ensuring a holistic approach to community and business development.